MedTrace Logo

Immunomodulatory Effect of Vitamin D in Allogenic Post-transplant

NCT02600988 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2015-11-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether vitamin D is effective in the prevention of graft-versus-host-disease after completion of allogeneic transplant.

Conditions

  • Hematopoietic Stem Cell Transplantation

Interventions

DRUG

1000IU/day of Vitamine D

Administration of a specified dose of Vitamine D

DRUG

5000IU/day of Vitamine D

Administration of a specified dose of Vitamine D

Sponsors & Collaborators

  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

    lead OTHER

Principal Investigators

  • José Antonio Pérez-Simón, MD-PhD · Head of haematology department

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02600988 on ClinicalTrials.gov